Valve regurgitation in patients surviving endocarditis and the subsequent risk of heart failure
BackgroundSignificant valve regurgitation is common in patients surviving native valve infective endocarditis (IE), however the associated risk of heart failure (HF) subsequent to hospital discharge after IE is sparsely described.MethodsWe linked data from the East Danish Endocarditis Registry with...
Gespeichert in:
Veröffentlicht in: | Heart (British Cardiac Society) 2020-07, Vol.106 (13), p.1015-1022 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1022 |
---|---|
container_issue | 13 |
container_start_page | 1015 |
container_title | Heart (British Cardiac Society) |
container_volume | 106 |
creator | Østergaard, Lauge Dahl, Anders Bruun, Niels Eske Oestergaard, Louise Bruun Lauridsen, Trine Kiilerich Torp-Pedersen, Christian Mortensen, Rikke Smerup, Morten Valeur, Nana Koeber, Lars Hassager, Christian Ihlemann, Nikolaj Fosbøl, Emil Loldrup |
description | BackgroundSignificant valve regurgitation is common in patients surviving native valve infective endocarditis (IE), however the associated risk of heart failure (HF) subsequent to hospital discharge after IE is sparsely described.MethodsWe linked data from the East Danish Endocarditis Registry with administrative registries from 2002 to 2016 and included patients treated medically for IE who were discharged alive. Left-sided valve regurgitation was assessed by echocardiography at IE discharge and examined for longitudinal risk of HF. Multivariable adjusted Cox analysis was used to assess the associated risk of HF in patients with regurgitation (moderate or severe) compared with patients without regurgitation.ResultsWe included 192 patients, 87 patients with regurgitation at discharge (30 with aortic regurgitation and 57 with mitral regurgitation) and 105 patients without. The cumulative risk of HF at 5 years of follow-up was 28.7% in patients with regurgitation at IE discharge and 12.4% in patients without regurgitation; the corresponding multivariable adjusted HR was 3.53 (95% CI 1.72 to 7.25). We identified an increased associated risk of HF for patients with aortic regurgitation (HR=2.91, 95% CI 1.14 to 7.43) and mitral regurgitation (HR=3.95, 95% CI 1.80 to 8.67) compared with patients without regurgitation. During follow-up, 21.9% and 5.7% underwent left-sided valve surgery among patients with and without regurgitation.ConclusionIn patients surviving IE, treated medically, we observed that severe or moderate left-sided native valve regurgitation was associated with a significantly higher risk of HF compared with patients without regurgitation at IE discharge. Close monitoring of these patients is needed to initiate surgery timely. |
doi_str_mv | 10.1136/heartjnl-2019-315715 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2324916383</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2324916383</sourcerecordid><originalsourceid>FETCH-LOGICAL-b393t-6fb215dce82fd762d3e782380ebdc1f3abecac6f163a1d1a57f1838066596b273</originalsourceid><addsrcrecordid>eNqNkV1LwzAUhoMobk7_gRcBb7ypS3LatL2U4RcMvFHxLqRtsmV26UzSgf_ezPoBXohXOeQ8z-GFF6FTSi4oBT5dKunCyrYJI7RMgGY5zfbQmKa82H0978cZsizhBPIROvJ-RQhJy4IfohHQgrEsJ2MknmS7VdipRe8WJshgOouNxZs4KRs89r3bmq2xC6xs09XSNSYYj6VtcFiquK68eu0jip3xL7jT-CMY1tK0vVPH6EDL1quTz3eCHq-vHma3yfz-5m52OU8qKCEkXFeMZk2tCqabnLMGVF4wKIiqmppqkJWqZc015SBpQ2WWa1rENedZySuWwwSdD3c3rotxfBBr42vVttKqrveCAUvLaBcQ0bNf6KrrnY3pBEsBGKRASKTSgapd571TWmycWUv3JigRuwLEVwFiV4AYCojadNCq9eq_BvkxvpP8qbwDlcSZhw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2433234300</pqid></control><display><type>article</type><title>Valve regurgitation in patients surviving endocarditis and the subsequent risk of heart failure</title><source>PubMed Central</source><creator>Østergaard, Lauge ; Dahl, Anders ; Bruun, Niels Eske ; Oestergaard, Louise Bruun ; Lauridsen, Trine Kiilerich ; Torp-Pedersen, Christian ; Mortensen, Rikke ; Smerup, Morten ; Valeur, Nana ; Koeber, Lars ; Hassager, Christian ; Ihlemann, Nikolaj ; Fosbøl, Emil Loldrup</creator><creatorcontrib>Østergaard, Lauge ; Dahl, Anders ; Bruun, Niels Eske ; Oestergaard, Louise Bruun ; Lauridsen, Trine Kiilerich ; Torp-Pedersen, Christian ; Mortensen, Rikke ; Smerup, Morten ; Valeur, Nana ; Koeber, Lars ; Hassager, Christian ; Ihlemann, Nikolaj ; Fosbøl, Emil Loldrup</creatorcontrib><description>BackgroundSignificant valve regurgitation is common in patients surviving native valve infective endocarditis (IE), however the associated risk of heart failure (HF) subsequent to hospital discharge after IE is sparsely described.MethodsWe linked data from the East Danish Endocarditis Registry with administrative registries from 2002 to 2016 and included patients treated medically for IE who were discharged alive. Left-sided valve regurgitation was assessed by echocardiography at IE discharge and examined for longitudinal risk of HF. Multivariable adjusted Cox analysis was used to assess the associated risk of HF in patients with regurgitation (moderate or severe) compared with patients without regurgitation.ResultsWe included 192 patients, 87 patients with regurgitation at discharge (30 with aortic regurgitation and 57 with mitral regurgitation) and 105 patients without. The cumulative risk of HF at 5 years of follow-up was 28.7% in patients with regurgitation at IE discharge and 12.4% in patients without regurgitation; the corresponding multivariable adjusted HR was 3.53 (95% CI 1.72 to 7.25). We identified an increased associated risk of HF for patients with aortic regurgitation (HR=2.91, 95% CI 1.14 to 7.43) and mitral regurgitation (HR=3.95, 95% CI 1.80 to 8.67) compared with patients without regurgitation. During follow-up, 21.9% and 5.7% underwent left-sided valve surgery among patients with and without regurgitation.ConclusionIn patients surviving IE, treated medically, we observed that severe or moderate left-sided native valve regurgitation was associated with a significantly higher risk of HF compared with patients without regurgitation at IE discharge. Close monitoring of these patients is needed to initiate surgery timely.</description><identifier>ISSN: 1355-6037</identifier><identifier>EISSN: 1468-201X</identifier><identifier>DOI: 10.1136/heartjnl-2019-315715</identifier><identifier>PMID: 31822570</identifier><language>eng</language><publisher>London: BMJ Publishing Group Ltd and British Cardiovascular Society</publisher><subject>Aortic regurgitation ; Cardiac surgery ; Endocarditis ; Heart failure ; Hospitals ; Mitral regurgitation ; Pacemakers ; Patients ; Software ; Studies ; Surgery ; Valvular heart disease</subject><ispartof>Heart (British Cardiac Society), 2020-07, Vol.106 (13), p.1015-1022</ispartof><rights>Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.</rights><rights>2020 Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b393t-6fb215dce82fd762d3e782380ebdc1f3abecac6f163a1d1a57f1838066596b273</citedby><cites>FETCH-LOGICAL-b393t-6fb215dce82fd762d3e782380ebdc1f3abecac6f163a1d1a57f1838066596b273</cites><orcidid>0000-0003-3298-1467</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Østergaard, Lauge</creatorcontrib><creatorcontrib>Dahl, Anders</creatorcontrib><creatorcontrib>Bruun, Niels Eske</creatorcontrib><creatorcontrib>Oestergaard, Louise Bruun</creatorcontrib><creatorcontrib>Lauridsen, Trine Kiilerich</creatorcontrib><creatorcontrib>Torp-Pedersen, Christian</creatorcontrib><creatorcontrib>Mortensen, Rikke</creatorcontrib><creatorcontrib>Smerup, Morten</creatorcontrib><creatorcontrib>Valeur, Nana</creatorcontrib><creatorcontrib>Koeber, Lars</creatorcontrib><creatorcontrib>Hassager, Christian</creatorcontrib><creatorcontrib>Ihlemann, Nikolaj</creatorcontrib><creatorcontrib>Fosbøl, Emil Loldrup</creatorcontrib><title>Valve regurgitation in patients surviving endocarditis and the subsequent risk of heart failure</title><title>Heart (British Cardiac Society)</title><addtitle>Heart</addtitle><description>BackgroundSignificant valve regurgitation is common in patients surviving native valve infective endocarditis (IE), however the associated risk of heart failure (HF) subsequent to hospital discharge after IE is sparsely described.MethodsWe linked data from the East Danish Endocarditis Registry with administrative registries from 2002 to 2016 and included patients treated medically for IE who were discharged alive. Left-sided valve regurgitation was assessed by echocardiography at IE discharge and examined for longitudinal risk of HF. Multivariable adjusted Cox analysis was used to assess the associated risk of HF in patients with regurgitation (moderate or severe) compared with patients without regurgitation.ResultsWe included 192 patients, 87 patients with regurgitation at discharge (30 with aortic regurgitation and 57 with mitral regurgitation) and 105 patients without. The cumulative risk of HF at 5 years of follow-up was 28.7% in patients with regurgitation at IE discharge and 12.4% in patients without regurgitation; the corresponding multivariable adjusted HR was 3.53 (95% CI 1.72 to 7.25). We identified an increased associated risk of HF for patients with aortic regurgitation (HR=2.91, 95% CI 1.14 to 7.43) and mitral regurgitation (HR=3.95, 95% CI 1.80 to 8.67) compared with patients without regurgitation. During follow-up, 21.9% and 5.7% underwent left-sided valve surgery among patients with and without regurgitation.ConclusionIn patients surviving IE, treated medically, we observed that severe or moderate left-sided native valve regurgitation was associated with a significantly higher risk of HF compared with patients without regurgitation at IE discharge. Close monitoring of these patients is needed to initiate surgery timely.</description><subject>Aortic regurgitation</subject><subject>Cardiac surgery</subject><subject>Endocarditis</subject><subject>Heart failure</subject><subject>Hospitals</subject><subject>Mitral regurgitation</subject><subject>Pacemakers</subject><subject>Patients</subject><subject>Software</subject><subject>Studies</subject><subject>Surgery</subject><subject>Valvular heart disease</subject><issn>1355-6037</issn><issn>1468-201X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqNkV1LwzAUhoMobk7_gRcBb7ypS3LatL2U4RcMvFHxLqRtsmV26UzSgf_ezPoBXohXOeQ8z-GFF6FTSi4oBT5dKunCyrYJI7RMgGY5zfbQmKa82H0978cZsizhBPIROvJ-RQhJy4IfohHQgrEsJ2MknmS7VdipRe8WJshgOouNxZs4KRs89r3bmq2xC6xs09XSNSYYj6VtcFiquK68eu0jip3xL7jT-CMY1tK0vVPH6EDL1quTz3eCHq-vHma3yfz-5m52OU8qKCEkXFeMZk2tCqabnLMGVF4wKIiqmppqkJWqZc015SBpQ2WWa1rENedZySuWwwSdD3c3rotxfBBr42vVttKqrveCAUvLaBcQ0bNf6KrrnY3pBEsBGKRASKTSgapd571TWmycWUv3JigRuwLEVwFiV4AYCojadNCq9eq_BvkxvpP8qbwDlcSZhw</recordid><startdate>20200701</startdate><enddate>20200701</enddate><creator>Østergaard, Lauge</creator><creator>Dahl, Anders</creator><creator>Bruun, Niels Eske</creator><creator>Oestergaard, Louise Bruun</creator><creator>Lauridsen, Trine Kiilerich</creator><creator>Torp-Pedersen, Christian</creator><creator>Mortensen, Rikke</creator><creator>Smerup, Morten</creator><creator>Valeur, Nana</creator><creator>Koeber, Lars</creator><creator>Hassager, Christian</creator><creator>Ihlemann, Nikolaj</creator><creator>Fosbøl, Emil Loldrup</creator><general>BMJ Publishing Group Ltd and British Cardiovascular Society</general><general>BMJ Publishing Group LTD</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-3298-1467</orcidid></search><sort><creationdate>20200701</creationdate><title>Valve regurgitation in patients surviving endocarditis and the subsequent risk of heart failure</title><author>Østergaard, Lauge ; Dahl, Anders ; Bruun, Niels Eske ; Oestergaard, Louise Bruun ; Lauridsen, Trine Kiilerich ; Torp-Pedersen, Christian ; Mortensen, Rikke ; Smerup, Morten ; Valeur, Nana ; Koeber, Lars ; Hassager, Christian ; Ihlemann, Nikolaj ; Fosbøl, Emil Loldrup</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b393t-6fb215dce82fd762d3e782380ebdc1f3abecac6f163a1d1a57f1838066596b273</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Aortic regurgitation</topic><topic>Cardiac surgery</topic><topic>Endocarditis</topic><topic>Heart failure</topic><topic>Hospitals</topic><topic>Mitral regurgitation</topic><topic>Pacemakers</topic><topic>Patients</topic><topic>Software</topic><topic>Studies</topic><topic>Surgery</topic><topic>Valvular heart disease</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Østergaard, Lauge</creatorcontrib><creatorcontrib>Dahl, Anders</creatorcontrib><creatorcontrib>Bruun, Niels Eske</creatorcontrib><creatorcontrib>Oestergaard, Louise Bruun</creatorcontrib><creatorcontrib>Lauridsen, Trine Kiilerich</creatorcontrib><creatorcontrib>Torp-Pedersen, Christian</creatorcontrib><creatorcontrib>Mortensen, Rikke</creatorcontrib><creatorcontrib>Smerup, Morten</creatorcontrib><creatorcontrib>Valeur, Nana</creatorcontrib><creatorcontrib>Koeber, Lars</creatorcontrib><creatorcontrib>Hassager, Christian</creatorcontrib><creatorcontrib>Ihlemann, Nikolaj</creatorcontrib><creatorcontrib>Fosbøl, Emil Loldrup</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Heart (British Cardiac Society)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Østergaard, Lauge</au><au>Dahl, Anders</au><au>Bruun, Niels Eske</au><au>Oestergaard, Louise Bruun</au><au>Lauridsen, Trine Kiilerich</au><au>Torp-Pedersen, Christian</au><au>Mortensen, Rikke</au><au>Smerup, Morten</au><au>Valeur, Nana</au><au>Koeber, Lars</au><au>Hassager, Christian</au><au>Ihlemann, Nikolaj</au><au>Fosbøl, Emil Loldrup</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Valve regurgitation in patients surviving endocarditis and the subsequent risk of heart failure</atitle><jtitle>Heart (British Cardiac Society)</jtitle><stitle>Heart</stitle><date>2020-07-01</date><risdate>2020</risdate><volume>106</volume><issue>13</issue><spage>1015</spage><epage>1022</epage><pages>1015-1022</pages><issn>1355-6037</issn><eissn>1468-201X</eissn><abstract>BackgroundSignificant valve regurgitation is common in patients surviving native valve infective endocarditis (IE), however the associated risk of heart failure (HF) subsequent to hospital discharge after IE is sparsely described.MethodsWe linked data from the East Danish Endocarditis Registry with administrative registries from 2002 to 2016 and included patients treated medically for IE who were discharged alive. Left-sided valve regurgitation was assessed by echocardiography at IE discharge and examined for longitudinal risk of HF. Multivariable adjusted Cox analysis was used to assess the associated risk of HF in patients with regurgitation (moderate or severe) compared with patients without regurgitation.ResultsWe included 192 patients, 87 patients with regurgitation at discharge (30 with aortic regurgitation and 57 with mitral regurgitation) and 105 patients without. The cumulative risk of HF at 5 years of follow-up was 28.7% in patients with regurgitation at IE discharge and 12.4% in patients without regurgitation; the corresponding multivariable adjusted HR was 3.53 (95% CI 1.72 to 7.25). We identified an increased associated risk of HF for patients with aortic regurgitation (HR=2.91, 95% CI 1.14 to 7.43) and mitral regurgitation (HR=3.95, 95% CI 1.80 to 8.67) compared with patients without regurgitation. During follow-up, 21.9% and 5.7% underwent left-sided valve surgery among patients with and without regurgitation.ConclusionIn patients surviving IE, treated medically, we observed that severe or moderate left-sided native valve regurgitation was associated with a significantly higher risk of HF compared with patients without regurgitation at IE discharge. Close monitoring of these patients is needed to initiate surgery timely.</abstract><cop>London</cop><pub>BMJ Publishing Group Ltd and British Cardiovascular Society</pub><pmid>31822570</pmid><doi>10.1136/heartjnl-2019-315715</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0003-3298-1467</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1355-6037 |
ispartof | Heart (British Cardiac Society), 2020-07, Vol.106 (13), p.1015-1022 |
issn | 1355-6037 1468-201X |
language | eng |
recordid | cdi_proquest_miscellaneous_2324916383 |
source | PubMed Central |
subjects | Aortic regurgitation Cardiac surgery Endocarditis Heart failure Hospitals Mitral regurgitation Pacemakers Patients Software Studies Surgery Valvular heart disease |
title | Valve regurgitation in patients surviving endocarditis and the subsequent risk of heart failure |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T04%3A41%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Valve%20regurgitation%20in%20patients%20surviving%20endocarditis%20and%20the%20subsequent%20risk%20of%20heart%20failure&rft.jtitle=Heart%20(British%20Cardiac%20Society)&rft.au=%C3%98stergaard,%20Lauge&rft.date=2020-07-01&rft.volume=106&rft.issue=13&rft.spage=1015&rft.epage=1022&rft.pages=1015-1022&rft.issn=1355-6037&rft.eissn=1468-201X&rft_id=info:doi/10.1136/heartjnl-2019-315715&rft_dat=%3Cproquest_cross%3E2324916383%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2433234300&rft_id=info:pmid/31822570&rfr_iscdi=true |